212 related articles for article (PubMed ID: 25940785)
1. Rosiglitazone-activated PPARγ induces neurotrophic factor-α1 transcription contributing to neuroprotection.
Thouennon E; Cheng Y; Falahatian V; Cawley NX; Loh YP
J Neurochem; 2015 Aug; 134(3):463-70. PubMed ID: 25940785
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor gamma up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis.
Fuenzalida K; Quintanilla R; Ramos P; Piderit D; Fuentealba RA; Martinez G; Inestrosa NC; Bronfman M
J Biol Chem; 2007 Dec; 282(51):37006-15. PubMed ID: 17965419
[TBL] [Abstract][Full Text] [Related]
3. The neuroprotective role of rosiglitazone in advanced glycation end product treated human neural stem cells is PPARgamma-dependent.
Chiang MC; Cheng YC; Nicol CJ; Lin CH
Int J Biochem Cell Biol; 2017 Nov; 92():121-133. PubMed ID: 28964868
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway.
Zhang HL; Xu M; Wei C; Qin AP; Liu CF; Hong LZ; Zhao XY; Liu J; Qin ZH
Neuroscience; 2011 Mar; 176():381-95. PubMed ID: 21185913
[TBL] [Abstract][Full Text] [Related]
5. PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms.
Yi JH; Park SW; Brooks N; Lang BT; Vemuganti R
Brain Res; 2008 Dec; 1244():164-72. PubMed ID: 18948087
[TBL] [Abstract][Full Text] [Related]
6. Neurotrophic factor-α1 prevents stress-induced depression through enhancement of neurogenesis and is activated by rosiglitazone.
Cheng Y; Rodriguiz RM; Murthy SR; Senatorov V; Thouennon E; Cawley NX; Aryal DK; Ahn S; Lecka-Czernik B; Wetsel WC; Loh YP
Mol Psychiatry; 2015 Jun; 20(6):744-54. PubMed ID: 25330741
[TBL] [Abstract][Full Text] [Related]
7. Novel interaction between neurotrophic factor-α1/carboxypeptidase E and serotonin receptor, 5-HTR1E, protects human neurons against oxidative/neuroexcitotoxic stress via β-arrestin/ERK signaling.
Sharma VK; Yang X; Kim SK; Mafi A; Saiz-Sanchez D; Villanueva-Anguita P; Xiao L; Inoue A; Goddard WA; Loh YP
Cell Mol Life Sci; 2021 Dec; 79(1):24. PubMed ID: 34966948
[TBL] [Abstract][Full Text] [Related]
8. Rosiglitazone attenuates hypoxia-induced renal cell apoptosis by inhibiting NF-κB signaling pathway in a PPARγ-dependent manner.
Wei JY; Hu MY; Chen XQ; Lei FY; Wei JS; Chen J; Qin XK; Qin YH
Ren Fail; 2022 Dec; 44(1):2056-2065. PubMed ID: 36420656
[TBL] [Abstract][Full Text] [Related]
9. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
[TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone activation of PPARγ-dependent signaling is neuroprotective in mutant huntingtin expressing cells.
Chiang MC; Cheng YC; Nicol CJ; Lin KH; Yen CH; Chen SJ; Huang RN
Exp Cell Res; 2015 Nov; 338(2):183-93. PubMed ID: 26362846
[TBL] [Abstract][Full Text] [Related]
11. Hydroxysafflor Yellow A Shows Protection against PPAR
Sun L; Xu YW; Han J; Xiao C; Cao SS; Liang H; Cheng Y
Oxid Med Cell Longev; 2018; 2018():9101740. PubMed ID: 30410641
[TBL] [Abstract][Full Text] [Related]
12. Curcumin protects neurons against oxygen-glucose deprivation/reoxygenation-induced injury through activation of peroxisome proliferator-activated receptor-γ function.
Liu ZJ; Liu HQ; Xiao C; Fan HZ; Huang Q; Liu YH; Wang Y
J Neurosci Res; 2014 Nov; 92(11):1549-59. PubMed ID: 24975470
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents.
Tureyen K; Kapadia R; Bowen KK; Satriotomo I; Liang J; Feinstein DL; Vemuganti R
J Neurochem; 2007 Apr; 101(1):41-56. PubMed ID: 17394460
[TBL] [Abstract][Full Text] [Related]
14. Prevention of JNK phosphorylation as a mechanism for rosiglitazone in neuroprotection after transient cerebral ischemia: activation of dual specificity phosphatase.
Okami N; Narasimhan P; Yoshioka H; Sakata H; Kim GS; Jung JE; Maier CM; Chan PH
J Cereb Blood Flow Metab; 2013 Jan; 33(1):106-14. PubMed ID: 23032483
[TBL] [Abstract][Full Text] [Related]
15. Rosiglitazone activation of PPARγ-dependent pathways is neuroprotective in human neural stem cells against amyloid-beta-induced mitochondrial dysfunction and oxidative stress.
Chiang MC; Nicol CJ; Cheng YC; Lin KH; Yen CH; Lin CH
Neurobiol Aging; 2016 Apr; 40():181-190. PubMed ID: 26973118
[TBL] [Abstract][Full Text] [Related]
16. Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection.
Romera C; Hurtado O; Mallolas J; Pereira MP; Morales JR; Romera A; Serena J; Vivancos J; Nombela F; Lorenzo P; Lizasoain I; Moro MA
J Cereb Blood Flow Metab; 2007 Jul; 27(7):1327-38. PubMed ID: 17213861
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human insulin gene transcription by peroxisome proliferator-activated receptor gamma and thiazolidinedione oral antidiabetic drugs.
Schinner S; Krätzner R; Baun D; Dickel C; Blume R; Oetjen E
Br J Pharmacol; 2009 Jul; 157(5):736-45. PubMed ID: 19338578
[TBL] [Abstract][Full Text] [Related]
18. Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins.
Wu JS; Lin TN; Wu KK
J Cell Physiol; 2009 Jul; 220(1):58-71. PubMed ID: 19229877
[TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone Suppresses In Vitro Seizures in Hippocampal Slice by Inhibiting Presynaptic Glutamate Release in a Model of Temporal Lobe Epilepsy.
Wong SB; Cheng SJ; Hung WC; Lee WT; Min MY
PLoS One; 2015; 10(12):e0144806. PubMed ID: 26659605
[TBL] [Abstract][Full Text] [Related]
20. Rosiglitazone decreases peroxisome proliferator receptor-γ levels in microglia and inhibits TNF-α production: new evidences on neuroprotection in a progressive Parkinson's disease model.
Carta AR; Frau L; Pisanu A; Wardas J; Spiga S; Carboni E
Neuroscience; 2011 Oct; 194():250-61. PubMed ID: 21839812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
